Foreign
Desk
| May 14, 2003, Wednesday
Experimental Drug May Fight SARS,
Researchers Say
By DENISE GRADY and LAWRENCE K.
ALTMAN (NYT) 907 words
Late Edition - Final , Section A ,
Page 6 , Column 1
ABSTRACT
- German researchers say that experimental
Pfizer drug AG-7088, which was tested and
shelved as common cold remedy, may, with
some chemical tinkering, be used to fight
SARS virus; Pfizer did not apply for FDA
approval and modification would take several
years; researcher Dr David Ho says in Hong
Kong that he and colleages at Aaron Diamond
AIDS Research Center in New York have
synthesized several peptides that could
prevent SARS from entering human cells, but
that will also take years of testing (M) An
experimental drug tested as a common cold
remedy and then shelved may, with chemical
tinkering, fight the virus that causes
severe acute respiratory syndrome,
researchers reported yesterday.
The scientists said their work would not
help victims of the current SARS epidemic,
because even if their findings are correct,
it will take several years to develop and
test new drugs. The study, by researchers
from several universities in Germany, were
led by Dr. Rolf Hilgenfeld, from the
University of Lübeck. Their report was
published online yesterday by the journal
Science.
How multi-packs work: A
multi-pack is an archive package that saves
you money by allowing you to pre-purchase a
set number of articles in bulk at a reduced
price. You can then debit from your
multi-pack and quickly access articles from
the archive at your convenience over the
lifetime of the multi-pack.
Once you purchase an
article, you may view it as often as you
like over the next 90 days. Archive articles
do not include photos, charts or graphics
Click here to purchase article if you
already own an archive article pack.
|
